e-Article
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
Barr, Mayalin; Blanchfield, J Lori; Bluestone, Jeffrey A; Buchanan, Jeanne; Bundy, Brian N; Cabbage, Joanne; Coleman, Peter; De La Vega, Monica; DiMeglio, Linda A; Evans-Molina, Carmella; Felner, Eric I; Ferrannini, Ele; Ferrara, Christine; Gaglia, Jason L; Gitelman, Stephen E; Gottlieb, Peter A; Healy, Felicity; Higgins, Laurie; Hildinger, Megan; Jenkins, Margaret; Kayton Bryant, Nora; Kinderman, Amanda; Koshy, Nisha; Kost, Brianne; Krischer, Jeffrey P; Krishfield, Suzanne; Kucheruk, Olena; Lim, Noha; Lindsley, Karen; Long, S Alice; Mantravadi, Manasa; Mari, Andrea; Mesfin, Shelley; Michels, Aaron; Migre, Mary Ellen; Minnock, Pantea; Mirmira, Raghavendra G; Mohammed-Nur, Elham; Nelson, Jennifer; Nursing, Ashvin; O'Donnell, Ryan; Olivos, Diana; Parker, Melissa; Raskin, Philip; Redl, Leanne; Reed, Nicole; Resnick, Brittany; Sanda, Srinath; Sayre, Peter; Serti, Elisavet; Sims, Emily; Smith, Karen; Soppe, Carol; Stuart, Fiona; Szubowicz, Sarah; Tansey, Michel; Terrell, Jennifer; Tersey, Sarah; Torok, Christine; Tsalikian, Eva; Watson, Kelly; Wentworth, John M; Wesch, Rebecca; Willi, Steven; Woerner, Stephanie; Willi, Steven M
Source
In The Lancet Diabetes & Endocrinology August 2021 9(8):502-514
Subject
Language
ISSN
2213-8587